ACARIX Acarix AB

Notice of extra general meeting in Acarix AB

Notice of extra general meeting in Acarix AB

Press release July 17, 2019



Notice of extra general meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be held on Friday 16 August 2019, at 10.00 at World Trade Center, Jungmansgatan 12 in Malmö, Sweden.

Right to attend the extra general meeting and notice.





Shareholders wishing to attend the extra general meeting must:



  1. on the record date, which is Saturday 10 August 2019, be registered in the share register maintained by Euroclear Sweden AB (since the record day occurs on a Saturday a shareholder must be registered in the share register maintained by Euroclear no later than Friday 9 August 2019). Shareholders, whose shares are registered in the name of a nominee, must temporarily register the shares in their own name at Euroclear Sweden AB. Shareholders whose shares are registered in the name of a nominee must, no later than on Friday 9 August 2019, via their nominee, temporarily register the shares in their own name in order to be entitled to participate at the general meeting; and

     
  2. notify their participation and any advisers (no more than two) at the general meeting no later than Monday 12 August 2019. Notice of participation at the general meeting shall be sent by regular mail to Acarix AB, c/o World Trade Center Malmö, Skeppsgatan 19, 211 11 Malmö or by e-mail . Upon notification, the shareholder should state their full name, personal identification number or corporate registration number, address and telephone number, and, where applicable, details of representatives, proxy holders and advisors. A shareholder who wishes to be represented by proxy shall issue a written and dated proxy to the proxy holder. If the proxy is issued by a legal entity, a certified copy of the registration certificate or corresponding document ("Registration Certificate") shall be enclosed. The proxy must not be more than one year old, however, the proxy may be older if it is stated that it is valid for a longer term, maximum five years. The proxy in original and the Registration Certificate, if any, must be available at the general meeting and a copy should well before the meeting be sent to the Company by regular mail to the address stated above, and should, in order to facilitate the entrance to the general meeting, be at the Company's disposal no later than on 12 August 2019. A form proxy will be available for downloading on the Company´s website .

Proposed agenda:

  1. Opening of the meeting
  2. Election of the chairman of the general meeting
  3. Preparation and approval of voting list
  4. Election of one person to certify the minutes
  5. Determination of whether the general meeting has been duly convened
  6. Approval of the agenda
  7. Resolution regarding amendments of the articles of association regarding the limits for the number of shares and the share capital
  8. Resolution regarding authorization for the board to issue shares (rights issue)
  9. Closing of the meeting

Proposals for resolutions:

Item 2: Election of the chairman of the general meeting

The board of directors proposes that Ian Gulam, LL.M., Baker & McKenzie Advokatbyrå, is appointed as chairman of the general meeting.

Item 7: Resolution regarding amendments of the articles of association regarding the limits for the number of shares and the share capital

The board of directors of the Company proposes that the extra general meeting resolves to amend the Company's articles of association as follows:

It is proposed that the limits for the share capital in the articles of association are changed from a minimum of SEK 15,000,000 and a maximum of SEK 60,000,000 to a minimum of SEK 23,000,000 and a maximum of SEK 92,000,000. The articles of association § 4 will thereby have the following wording:

"The share capital shall not be less than SEK 23,000,000 and not more than SEK 92,000,000."

It is also proposed that the limits for the number of shares in the articles of association are changed from a minimum of 15,000,000 and a maximum of 60,000,000 to a minimum of SEK 23,000,000 and a maximum of 92,000,000. The articles of association § 5 will thereby have the following wording

"The number of shares shall not be less than 23,000,000 and not more than 92,000,000."

A technical adjustment is also proposed regarding § 1 with respect to the Company name due to changes of the Swedish Companies Act where "firma" is no longer used, and which has been replaced with "företagsnamn".

It is finally proposed that the board of directors or a person appointed by the board of directors be authorized to make such minor adjustments in the above resolution that may be required in connection with the registration with the Swedish Companies Registration Office.

Item 8: Resolution regarding authorization for the board to issue shares (rights issue)

The board of directors of the Company proposes that the extra general meeting resolves to authorize the board of directors during the period up until the next annual general meeting to, on one or more occasions, resolve to issue shares, within the limits of the articles of association, with preferential rights for the shareholders, to be paid in cash, in kind and/or by way of set-off.

The reasons for the authorization are to increase the Company's flexibility in connection with entering into new markets and to advance the commercialization of the Company's existing projects.

Issuances of new shares under the authorization shall be made on customary terms and conditions based on current market conditions.

The board of directors or a person appointed by the board of directors shall be authorized to make such minor adjustments in the above resolution that may be required in connection with the registration with the Swedish Companies Registration Office.

Majority requirements

A resolution in accordance with item 7 requires support by shareholders holding not less than two-thirds of both the shares voted and of the shares represented at the general meeting.

Number of shares and votes

The total number of shares in the Company as of the date hereof amounts to 23,027,376 shares, with a corresponding number of votes. The Company holds no own shares.

Further information

Complete proposals including the proposed articles of association, proxy forms and other documents that shall be made available in accordance with the Swedish Companies Act are available at the Company at c/o World Trade Center Malmö, Skeppsgatan 19 in Malmö and at the Company's website , at least three (3) weeks in advance of the extra general meeting and will be sent to shareholders who request it and provide their e-mail or postal address.

The shareholders hereby notified regarding the right to, at the extra general meeting, request information from the board of directors and managing director according to Ch. 7 § 32 of the Swedish Companies Act.

Processing of personal data

For information on how personal data is processed in relation the meeting, see the Privacy notice available on Euroclear Sweden AB's website: /dam/ESw/Legal/Privacy-notice-bolagsstammorengelska.pdf.

*****

Malmö in July 2019

Acarix AB

The board of directors

Attachment

EN
17/07/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Acarix AB

Acarix AB: 1 director

A director at Acarix AB bought 2,300,257 shares at 0.222SEK and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

Acarix partners with Strategic Health AK to roll-out CADScor®System ac...

Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska Press release Malmö, Sweden, June 22, 2022   Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska Acarix continues its US expansion by partnering with Strategic Health AK, a healthcare provider covering tribal and rural areas of Alaska. Acarix has received initial orders of CADScor®Systems to be used across health regions in Alaska. Providing health care to remote populations in Alaska is challenging, and cardiac care is no different. Alaskan natives h...

 PRESS RELEASE

Acarix tecknar samarbetsavtal med Strategic Health AK för att införa C...

Acarix tecknar samarbetsavtal med Strategic Health AK för att införa CADScor®System i Alaska Pressmeddelande Malmö, 22 juni, 2022  Acarix tecknar samarbetsavtal med Strategic Health AK för att införa CADScor®System i Alaska Acarix fortsätter sin USA-expansion genom ett samarbetsavtal med Strategic Health AK, en Alaska-baserad vårdgivare med särskilt fokus på Alaskas ursprungsbefolkning och patienter i landsbygdsområden. Acarix har erhållit initiala beställningar av CADScor®System som ska användas inom vårdregioner i Alaska. Att tillhandahålla hälsovård till avlägsna befolkningar i Ala...

 PRESS RELEASE

Acarix signs additional commercial agreement in US and receives order ...

Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana. Press release Malmö, Sweden, June 10, 2022   Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana. Acarix continues the US expansion with another commercial partnership now covering Louisiana and parts of Mississippi. This partnership with Bio-Rhythms Inc provides access to cardiology clinics, emergency departments and primary care clinics in geographic areas with high medical need for rapid and cost-effective rule-out of coronary artery d...

 PRESS RELEASE

Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller bestä...

Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller beställning på CADScor®System i Louisiana. Pressmeddelande Malmö, 10 juni, 2022   Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller beställning på CADScor®System i Louisiana. Acarix fortsätter att utöka täckningen i USA genom ytterligare ett kommersiellt partnerskap som täcker Louisiana och delar av Mississippi. Detta partnerskap med Bio-Rhythms Inc ger tillgång till kardiologiska mottagningar, akutmottagningar och primärvårdsmottagningar i geografiska områden med höga medicinska behov för snabb och kostnads...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch